Table 6 Cumulative cost analysis of all blood products (n = 104 patients)
From: Thrombelastometry guided blood-component therapy after cardiac surgery: a randomized study
Variables | CONTROL | ROTEM® |
|---|---|---|
Number | 52 (50) | 52 (50) |
intraoperative | ||
RBCs (70 €) | 3780 | 3290 |
FFPs (51 €) | 2346 | 1326 |
Platelet concentrates (unit: 500 €) | 4000 | 3500 |
Fibrinogen, 1 g (287.5 €) | 2013 | 1725 |
PPSB, 500 IU (120 €) | 1680 | 1560 |
AT3, 1000 IU (70 €) | 490 | 280 |
Aprotinin (2.5 Mio IU 123.75 €) | 668 | 2574 |
Tranexamic acid (500 mg: 7.63 €) | 1206 | 1373 |
Cumulative costs | 16,183 | 15,628 |
ICU (after randomization) | ||
RBCs (70 €) | 18,690 | 14,980 |
FFPs (51 €) | 8313 | 5559 |
Platelet concentrates (unit: 500 €) | 17,500 | 10,000 |
Fibrinogen, 1 g (287.5 €) | 2875 | 11,500 |
PPSB, 500 IU (120 €) | 720 | 960 |
AT3, 1000 IU (70 €) | 70 | 70 |
Aprotinin (2.5 Mio IU 123.75 €) | 1188 | 198 |
Tranexamic acid (500 mg: 7.63 €) | 61 | 31 |
Cumulative costs | 49,417 | 43,298 |
Overall cumulative costs [€] | 65,600 | 58,926 |
Costs per patient [€] | 1261.5 | 1133 |
Costs savings per patient [€] | – | 128.5 |